{
    "code": "02024996",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024996",
    "time": "2020-09-25 03:58:27",
    "許可證字號": "衛署藥輸字第024996號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "113\/03\/24",
    "發證日期": "98\/03\/24",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202499609",
    "中文品名": "利瑞卡膠囊 150 毫克",
    "英文品名": "Lyrica hard Capsule 150mg",
    "適應症": "成人局部癲癇的輔助治療、帶狀&#30129;疹後神經痛。纖維肌痛(fibromyalgia)。糖尿病周邊神經病變引起的神經性疼痛。\r\n脊髓損傷所引起的神經性疼痛。",
    "劑型": "130膠囊劑",
    "包裝": "2~1000粒鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "PREGABALIN",
    "限制項目": "02輸　入 58依本署891212衛署藥字第0890035812號公告經本署認定得免除國內銜接性試驗且經本署核定之新藥",
    "申請商名稱": "1504401100  輝瑞大藥廠股份有限公司",
    "申請商地址": "台北市信義路松仁路100號42、43樓",
    "主製造廠": [
        {
            "製造廠名稱": "FDE0247000  PFIZER MANUFACTURING DEUTSCHLAND GMBH",
            "製造廠廠址": "BETRIEBSSTATTE FREIBURG, MOOSWALDALLEE 1, 79090 FREIBURG, GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2812009200",
            "成分名稱": "PREGABALIN",
            "含量描述": "",
            "含量": "150.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "024997-109-09-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024996&Seq=004&Type=9"
        },
        {
            "title": "Lyrica 150-104-09-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024996&Seq=001&Type=8"
        }
    ]
}